Off-pump coronary artery bypass grafting in a heparin-induced thrombocytopenia type II patient using hirudin

C S Carr, A Rayner, J Ponte, J B Desai

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

Heparin is routinely used for anticoagulation during cardiopulmonary bypass; it is fast acting, is easily monitored, and has an antidote. Heparin-induced thrombocytopenia (HIT) can be a life-threatening condition requiring an alternative anticoagulant (hirudin) if cardiac surgical intervention is considered. At full anticoagulant doses, the effects of hirudin are difficult to monitor; therefore, we present a case in which off-pump coronary artery bypass grafting was performed in an HIT patient in whom the lower doses of hirudin could safely be monitored with easily available tests. (C) 2005 by The Society of Thoracic Surgeons.
Original languageEnglish
Pages (from-to)696 - 698
Number of pages3
JournalAnnals of Thoracic Surgery
Volume79
Issue number2
DOIs
Publication statusPublished - Feb 2005

Fingerprint

Dive into the research topics of 'Off-pump coronary artery bypass grafting in a heparin-induced thrombocytopenia type II patient using hirudin'. Together they form a unique fingerprint.

Cite this